Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: The Hard Right Over the Easy Wrong My Core Decision Upfront We disclose immediately. Not in 6 months, not after "more data," not after the earnings call. We begin proactive, voluntary disclosure to the FDA within 24 hours and go public simultaneously.Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer